erlotinib hydrochloride has been researched along with glycolipids in 2 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (glycolipids) | Trials (glycolipids) | Recent Studies (post-2010) (glycolipids) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 19,062 | 170 | 5,050 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, C; Jiang, J; Liu, Y; Ma, T; Xu, H | 1 |
| Cheon, SY; Han, S; Jang, SY; Koo, H; Lee, D; Lee, Y; Park, E | 1 |
2 other study(ies) available for erlotinib hydrochloride and glycolipids
| Article | Year |
|---|---|
Novel therapeutic modalities and drug delivery - erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigations.
Topics: Animals; Erlotinib Hydrochloride; Female; Glycolipids; Liposomes; Liver; Male; Mice; Rats | 2018 |
Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Therapy, Combination; Emulsions; Erlotinib Hydrochloride; Glycolipids; Mice; Nanoparticles; Optical Imaging | 2021 |